MYD88 mutation + CXCR4 mutation
|
Waldenstrom Macroglobulinemia
|
MYD88 mutation + CXCR4 mutation
|
Waldenstrom Macroglobulinemia
|
ibrutinib Sensitive: C2 – Inclusion Criteria
|
ibrutinib Sensitive: C2 – Inclusion Criteria
|
MYD88 mutation + CXCR4 mutation
|
Waldenstrom Macroglobulinemia
|
MYD88 mutation + CXCR4 mutation
|
Waldenstrom Macroglobulinemia
|
ibrutinib + X4P-001 Sensitive: C3 – Early Trials
|
ibrutinib + X4P-001 Sensitive: C3 – Early Trials
|